Context: Parkinson's disease (PD) is the second common progressive neurodegenerative
disease, distressing older men and is prevalent Worldwide. Objectives: This article is aimed …

Parkinson's disease (PD) is a chronic neurodegenerative disorder characterized by motor
symptoms such as bradykinesia, rest tremor, postural disturbances, and rigidity. PD is also …

dihydroxy‐L‐phenylalanine (L‐DOPA) is the gold standard treatment for Parkinson's
disease. It has earned that title through its highly effective treatment of some of the motor …

The potential of using wearable technologies for the objective assessment of motor
symptoms in Parkinson's disease (PD) has gained prominence recently. Nonetheless …

The active pharmaceutical ingredient rotigotine—a dopamine agonist for the treatment of
Parkinson's and restless leg diseases—was known to exist in only one polymorphic form …

Parkinson's disease is a chronic neurodegenerative movement disorder affecting people
mainly beyond their 50s. Geriatric patients with Parkinson's disease experience a specific …

Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Introduction: Dyskinesia is a motor complication of Parkinson's disease (PD) characterized
by clinical heterogeneity and complex pathogenesis and associated with long-term …

In this study, we present the application of a novel capillary electrophoresis (CE) method in
combination with label-free quantitation and support vector machine-based feature selection …

Abstract Objectives: Idiopathic Parkinson's Disease is a neurodegenerative disease caused
by the loss of cells that secrete dopamine in the basal ganglia. Galectins are multipotent …